Complex effects of imatinib on spontaneous and oxytocin-induced contractions in human non-pregnant myometrium. 2011

S M Cretoiu, and A A Simionescu, and L Caravia, and A Curici, and D Cretoiu, and L M Popescu
Department of Cellular and Molecular Medicine, 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania.

Human myometrium includes two important cell populations involved in its contractility: smooth muscle fibers and interstitial cells. The pacemaking mechanism is not yet identified, but it is possible that myometrial smooth muscle cells contract in response to a signal generated by c-kit positive interstitial cells. The aim of this study was to investigate the effects of imatinib as a c-kit receptor antagonist on the spontaneous or oxytocin (OT) induced contractions of human non-pregnant myometrium in vitro. Myometrial strips were obtained from non-pregnant women (reproductive age) undergoing hysterectomy for benign indications. The strips were suspended in organ baths for recording of isometric tension. Imatinib effects were assessed on spontaneous contraction and after preexposure to OT.Direct exposure of myometrial strips to imatinib inhibits both amplitude and frequency of contractions (80-320 μM) in a dose dependent manner. Amplitude reverted back to 90% of the baseline amplitude by consequent addition of imatinib (until 480 μM). Total inhibition of myometrial contraction was obtained after addition of OT 60 nM. If myometrium was pre-exposed to OT (320 nM), imatinib 80-160 μm increased amplitude, while decreasing frequency. These data provide evidence that telocytes may be involved as modulators of the spontaneous contractions of the non-pregnant human uterus, via a tyrosine-kinase independent signaling pathway.

UI MeSH Term Description Entries
D009215 Myometrium The smooth muscle coat of the uterus, which forms the main mass of the organ. Uterine Muscle,Muscle, Uterine,Muscles, Uterine,Uterine Muscles
D010120 Oxytocics Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions (ABORTIFACIENTS). Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. (From AMA Drug Evaluations, 1994, p1157) Oxytocic,Oxytocic Agent,Oxytocic Drug,Uterine Stimulant,Uterine Stimulants,Oxytocic Agents,Oxytocic Drugs,Oxytocic Effect,Oxytocic Effects,Agent, Oxytocic,Agents, Oxytocic,Drug, Oxytocic,Drugs, Oxytocic,Effect, Oxytocic,Effects, Oxytocic,Stimulant, Uterine,Stimulants, Uterine
D010121 Oxytocin A nonapeptide hormone released from the neurohypophysis (PITUITARY GLAND, POSTERIOR). It differs from VASOPRESSIN by two amino acids at residues 3 and 8. Oxytocin acts on SMOOTH MUSCLE CELLS, such as causing UTERINE CONTRACTIONS and MILK EJECTION. Ocytocin,Pitocin,Syntocinon
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068877 Imatinib Mesylate A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors. Alpha-(4-methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide,CGP 57148,CGP-57148,CGP57148B,Gleevec,Glivec,Imatinib,Imatinib Methanesulfonate,ST 1571,ST1571,STI 571,STI-571,STI571,CGP57148,Mesylate, Imatinib,Methanesulfonate, Imatinib
D001549 Benzamides BENZOIC ACID amides.

Related Publications

S M Cretoiu, and A A Simionescu, and L Caravia, and A Curici, and D Cretoiu, and L M Popescu
October 2005, Acta anaesthesiologica Scandinavica,
S M Cretoiu, and A A Simionescu, and L Caravia, and A Curici, and D Cretoiu, and L M Popescu
October 2017, Reproductive sciences (Thousand Oaks, Calif.),
S M Cretoiu, and A A Simionescu, and L Caravia, and A Curici, and D Cretoiu, and L M Popescu
March 2002, BJOG : an international journal of obstetrics and gynaecology,
S M Cretoiu, and A A Simionescu, and L Caravia, and A Curici, and D Cretoiu, and L M Popescu
May 1989, Biology of reproduction,
S M Cretoiu, and A A Simionescu, and L Caravia, and A Curici, and D Cretoiu, and L M Popescu
September 2013, Anesthesiology,
S M Cretoiu, and A A Simionescu, and L Caravia, and A Curici, and D Cretoiu, and L M Popescu
June 2001, Neuro endocrinology letters,
S M Cretoiu, and A A Simionescu, and L Caravia, and A Curici, and D Cretoiu, and L M Popescu
November 2011, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
S M Cretoiu, and A A Simionescu, and L Caravia, and A Curici, and D Cretoiu, and L M Popescu
September 1986, American journal of obstetrics and gynecology,
S M Cretoiu, and A A Simionescu, and L Caravia, and A Curici, and D Cretoiu, and L M Popescu
June 2014, Acta physiologica Hungarica,
S M Cretoiu, and A A Simionescu, and L Caravia, and A Curici, and D Cretoiu, and L M Popescu
November 1998, Pharmacology,
Copied contents to your clipboard!